Schizophrenia is a challenging diagnosis both domestically and across the world. Various treatment guidelines have been developed by key thought leaders to share perspectives on acute and long-term management of Schizophrenia. Join Jehan Marino, Senior Medical Science Liaison for Otsuka Pharmaceutical Development and Commercialization, as she moderates a robust discussion with Dr. Christoph Correll. Dr. Correll will provide his perspectives of schizophrenia guidelines development, with a focus on key similarities and differences.
Christoph Correll, MD
Chair of the Department of Child and Adolescent Psychiatry, Psychosomatic Medicine and Psychotherapy, Charité Universitätsmedizin Berlin, Campus Virchow, Berlin, Germany. Professor of Psychiatry at The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New York, USA.
Jehan Marino, PharmD, BCPP
Medical Science Liaison
Christoph Correll, MD, is a paid consultant for Otsuka Pharmaceutical Development & Commercialization, Inc.
Jehan Marino, PharmD, BCPP, is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.
This event registration is closed.
Notifications
